Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection
- 1 July 2015
- journal article
- review article
- Published by Elsevier BV in Pharmacological Research
- Vol. 97, 84-103
- https://doi.org/10.1016/j.phrs.2015.04.008
Abstract
No abstract availableKeywords
Funding Information
- National Council of Science and Technology, Mexico (177527)
This publication has 100 references indexed in Scilit:
- MicroRNA ‘signature’ during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid interventionCancer Letters, 2013
- Nuclear Receptors as Drug Targets in Cholestatic Liver DiseasesClinics in Liver Disease, 2013
- Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and DiagnosisPharmaceutical Research, 2013
- In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leavesFood and Chemical Toxicology, 2009
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implicationsJournal of Hepatology, 2009
- Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3′,4,4′-tetrachlorobiphenyl (PCB-77)Food and Chemical Toxicology, 2008
- Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in miceJournal of Hepatology, 2008
- NF-κB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicalsGenes & Nutrition, 2007
- Redox state in liver mitochondria in acute copper sulfate poisoningLife Sciences, 1994
- Dietary Ellagic Acid Inhibits the Enzymatic Activity of CYP1A1 without Altering Hepatic Concentrations of CYP1A1 or CYP1A1 mRNABiochemical and Biophysical Research Communications, 1994